Search
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
How Hovione grew from a basement lab to a global pharmaceutical services company
C&EN, November 12, 2018
Cleaning Continuous Manufacturing Equipment
Pharmaceutical Technology, 2 Junho 2021
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Continuous Flow
Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.